Maynard Um
-
-
-
-
-
-
-
Cadrenal seeks FDA meeting for HIT treatment drug VLX-1005
-
-
-
-
-
-
-
Cadrenal Therapeutics acquires eXIthera's Factor XIa inhibitor portfolio
-
-
-
-
-
-
-
Cadrenal Therapeutics (CVKD) PT Raised to $32 at H.C. Wainwright
-
-
-
-
-
418,141 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

